SYRS vs AAPL: Which Stock is Better?
Side-by-side comparison of Syros Pharmaceuticals Inc and Apple Inc in 2026
SYRS
Syros Pharmaceuticals Inc
$0.00
AAPL
Apple Inc
$269.84
Key Metrics Comparison
| Metric | SYRS | AAPL | Winner |
|---|---|---|---|
| Market Cap | $0.01M | N/A | SYRS |
| P/E Ratio | N/A | 33.32 | AAPL |
| EPS (TTM) | $N/A | $8.11 | AAPL |
| Revenue Growth | -0.0% | 0.2% | AAPL |
| Gross Margin | -22863.0% | 47.3% | AAPL |
Analyze SYRS
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is SYRS or AAPL a better investment?
Comparing SYRS and AAPL: Syros Pharmaceuticals Inc has a market cap of $0.01M while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between SYRS and AAPL?
SYRS (Syros Pharmaceuticals Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: SYRS or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: SYRS or AAPL?
AAPL has higher revenue growth at 0.2% vs -0.0% for SYRS.
Which company is more profitable: SYRS or AAPL?
Apple Inc (AAPL) has higher gross margins at 47.3% compared to -22863.0% for SYRS.
Which is the larger company: SYRS or AAPL?
Syros Pharmaceuticals Inc (SYRS) is larger with a market cap of $0.01M compared to N/A for AAPL.
Should I buy SYRS or AAPL in 2026?
Both SYRS and AAPL have investment merit. SYRS trades at $0.00 while AAPL trades at $269.84. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between SYRS and AAPL stock?
Key differences: Market Cap ($0.01M vs N/A), P/E Ratio (N/A vs 33.3x), Revenue Growth (-0.0% vs 0.2%), Gross Margin (-22863.0% vs 47.3%).